U.S. Expands Global Health Agreements to Strengthen Infectious Disease Response

In late 2025, the U.S. government unveiled the <span class="annotated" data-start="117" data-end="149">America First Global Health Strategy</span>, marking a fundamental shift in its approach to international assistance.

Moving away from traditional project-based aid, the U.S. is now establishing structured, multi-year <span class="annotated" data-start="269" data-get="300">Bilateral Memorandums of Understanding</span> (MOUs) with partner nations.

This strategy centers on three primary goals: enhancing disease surveillance, strengthening formal government-to-government partnerships, and protecting the U.S. economy.

A key component of these agreements is the <span class="annotated" data-start="538" data-end="543">7-1-7</span> framework, which aims to detect, report, and respond to infectious disease outbreaks within a specific rapid timeline.

Furthermore, the agreements require partners to increase domestic health spending, encouraging a transition toward local ownership of healthcare systems by 2030.

As of early 2026, the U.S. has finalized 24 such agreements, totaling over $20 billion in commitments.

While officials highlight increased efficiency and stronger strategic ties, some experts express concern regarding the feasibility of these ambitious timelines, especially in countries with limited government capacity or unstable environments.